Sector Chart BioRestorative Therapies, Inc.
Stocks
BRTX
US0906556065
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4000 USD | +3.73% |
|
+8.23% | -65.96% |
| 06-25 | BioRestorative Therapies Completes Manufacturing for BRTX-100 Phase 2 Clinical Trial | CI |
| 06-16 | BioRestorative Therapies, Inc.'s Equity Buyback announced on August 12, 2025, has expired. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 10.19M | - | - | - | ||
| 59.1B | |||||
| 55.19B | |||||
| 24.67B | - | ||||
| 24.19B | - | ||||
| 19.69B |
Select your edition
All financial news and data tailored to specific country editions
